Reuters logo
Aldagen Inc files to withdraw IPO plans
October 7, 2008 / 7:30 PM / 9 years ago

Aldagen Inc files to withdraw IPO plans

WASHINGTON, Oct 7 (Reuters) - Biopharmaceutical company Aldagen Inc filed with regulators on Tuesday to withdraw its plans for an $80.5 million initial public offering.

The company said it is withdrawing the IPO because of market conditions and its determination that the offering would not be in the best interest of the company at this time. (Reporting by Karey Wutkowski)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below